Foresite Capital Management Vi LLC Denali Therapeutics Inc. Transaction History
Foresite Capital Management Vi LLC
- $259 Billion
- Q3 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 1,000,000 shares of DNLI stock, worth $17.4 Million. This represents 5.61% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$17.4 Million% of portfolio
5.61%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
262Shares Held
133MCall Options Held
219KPut Options Held
107K-
Black Rock Inc. New York, NY13.2MShares$230 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$209 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$202 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.64MShares$98.3 Million0.05% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL5.47MShares$95.3 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.34B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...